SEARCH

SEARCH BY CITATION

References

  • 1
    Penn I. Lymphomas complicating organ transplantation. Transplant Proc 1983; 15(suppl 1):27902797.
  • 2
    Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988; 25:367372. MEDLINE
  • 3
    Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342:15141516. MEDLINE
  • 4
    Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV seroconversion and the lymphoproliferative syndrome in pediatric liver transplant recipient. Transplant Proc 1991; 23:14731476. MEDLINE
  • 5
    Stieber AC, Boillot O, Scotti Fogelieni C, Nalesnik MA, Gordon RD, Starzl TE. The surgical implications of posttransplant lymphoproliferative disorders. Transplant Proc 1991; 23:14771479. MEDLINE
  • 6
    Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Klintman G. De novo malignancy following liver transplantation: A single-center study. Transplant Proc 1993; 25:13971399. MEDLINE
  • 7
    Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL. Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation. Transplantation 1985; 39:461472. MEDLINE
  • 8
    Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323:17231728. MEDLINE
  • 9
    Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation. Transplant Proc 1993; 25:18701871. MEDLINE
  • 10
    Cen H, Williams PA, McWilliams HP, Breining MC, Ho M, McKnight JLC. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 1993; 81:13931403. MEDLINE
  • 11
    Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994; 97:1424. MEDLINE
  • 12
    The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored by study of classification of non-Hodgkin's lymphoma. Summary and description of a working formulation for clinical usage. Cancer 1982; 49:21122135. MEDLINE
  • 13
    Nalesnik MA. Posttransplantation lymphoproliferative disorders (PTLD): Current perspectives. Semin Thorac Cardiovasc Surg 1996; 8:139148. MEDLINE
  • 14
    Cleary M, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac transplant recipients: Clonal analysis based on immunoglobulin gene rearrangements. New Engl J Med 1984; 310:477482. MEDLINE
  • 15
    Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH. Immunohistology of Epstein-Barr virus–associated antigens in B cell disorders from immunocompromised individuals. Transplantation 1990; 49:944953. MEDLINE
  • 16
    Janossy G, Amlot PL. Immunofluorescence and immunohistochemistry. In: KlausGG, ed. Lymphocytes—A practical approach. Oxford: IRL Press, 1987; 67108.
  • 17
    Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM. Prognostic significance of the Ki67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group Trial. Blood 1994; 83:14601466. MEDLINE
  • 18
    Alfrey EJ, Friedman AL, Grossman RA, Perloff LJ, Naji A, Barker CF, et al. A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder. Transplantation 1992; 54:250253. MEDLINE
  • 19
    Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23:11011103. MEDLINE
  • 20
    Hanto DW, Frizzera G, Gajl-Peczalska K, Sakamoto K, Purtillo DT, Balfour HH, et al. Epstein-Barr virus–induced B-cell lymphoma after renal transplantation. N Engl J Med 1982; 306:913918. MEDLINE
  • 21
    Hanto DW, Gajl-Peczalska K, Frizzera G, Arthur DC, Balfour HH, McClain K, et al. Epstein-Barr virus (EBV)-induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation: Clinical, pathologic and virologic findings and implications for therapy. Ann Surg 1983; 198:356369. MEDLINE
  • 22
    Ho M, Miller G, Atchison RW, Breining MK, Dummer JS, Rosenthal JT. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection. J Infect Dis 1985; 152:876886. MEDLINE
  • 23
    Llyas M, Trendell SN, Snead D. Expression of Epstein-Barr virus in liver transplant recipients with lymphoproliferative disease. N Engl J Med 1993; 329:208209.
  • 24
    Hardarson S, Anderson ME, Latz CT. Presence of Epstein-Barr virus in many types of benign and malignant lymphoid lesions: Detection by polymerase chain reaction and in situ hybridization. Diagn Mol Pathol 1994; 3:2231. MEDLINE
  • 25
    Berg LC, Copenhaver CM, Morrison VA, Gruber SA, Dunn DL, Gajl-Peczalska K, et al. B-cell lymphoproliferative disorders in solid organ transplant patients: Detection of Epstein-Barr virus by in situ hybridization. Hum Pathol 1992; 23:159163. MEDLINE
  • 26
    Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Weiss LM. Expression of Epstein-Barr virus–encoded RNA (by EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 1992; 327:17101704. MEDLINE
  • 27
    Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation 1993; 56:8896. MEDLINE
  • 28
    Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995; 20:13461353. MEDLINE
  • 29
    Haque T, Thomas JA, Falk KI, Parratt R, Hunt BJ, Yacoub M, Crawford DH. Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. J Gen Viral 1996; 77:11691172.
  • 30
    Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG, et al. Development of monoclonal gammopathy precedes the development of Epstein-Barr virus–induced posttransplant lymphoproliferative disorder. Liver Transpl Surg 1996; 2:375382. MEDLINE
  • 31
    Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Bahnson HT. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 17:583588.
  • 32
    Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez DM, Krams SM, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995; 59:524529. MEDLINE
  • 33
    McAlister V, Grant D, Roy A, Yilmaz Z, Ghent C, Wall W. Post-transplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. Transplant Proc 1993; 25:14001401. MEDLINE
  • 34
    Bieber CP, Heberling RL, Jamieson SW, Oyer PE, Warnke MR, Saemundesen A, et al. Lymphoma in cardiac transplant recipients associated with cyclosporine A, prednisone and anti-thymocyte globulin (ATG). In: PurtiloDT, ed. Immune deficiency and cancer. New York: Plenum, 1984; 309.
  • 35
    Egan J, Stewart J, Yonan N, Arrand J, Woodcock A. Non-Hodgkin lymphoma in heart/lung transplant recipients. Lancet 1994; 343:481. MEDLINE
  • 36
    Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990; 336:519523. MEDLINE
  • 37
    Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor of chronic rejection of liver allografts. Lancet 1995; 346:11171121. MEDLINE
  • 38
    Marino IR, Doyle HR, Aldrighetti L, Doria C, McMichael J, Gayowski T, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22:17541762. MEDLINE
  • 39
    Raymond E, Tricottet V, Samuel D, Reynes M, Bismuth H, Misset JL. Epstein-Barr virus–related localized hepatic lymphoproliferative disorders after liver transplantation. Cancer 1995; 76:13441351. MEDLINE
  • 40
    Portmann B, Schindler AM, Murray LJM, Williams R. Histological sexing of a reticulum cell sarcoma arising after liver transplantation. Gastroenterology 1976; 70:8284. MEDLINE
  • 41
    Palazzo JP, Lundquist K, Mitchell D, Mittal KR, Hann HWL, Martin P. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis. Am J Gastroenterol 1993; 88:102104. MEDLINE
  • 42
    Spiro IJ, Yandell DW, Chuan Li SD, Saini S, Ferry J, Cosimi AB. Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med 1993; 329:2729. MEDLINE
  • 43
    Barkholt L, Billing H, Juliusson G, Porwit A, Ericzon B, Groth C. B-cell lymphoma in transplanted liver: Clinical, histological and radiological manifestations. Transplant Int 1991; 4:811.
  • 44
    McCarthy M, Ramage J, McNair A, Gane E, Portmann B, Pagliuca A, et al. The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients. J Hepatol 1997; 27:10151021. MEDLINE
  • 45
    Cleary ML, Nalesnik MA, Shearer WT, Sklar J. Clonal analysis of transplant-associated lymphoproliferation based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988; 72:349352. MEDLINE
  • 46
    Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose E, Michler RE. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of postransplantation lymphoproliferative disorders. Blood 1995; 85:562585.
  • 47
    Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Lindquist LL. Polymorphic diffuse B cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981; 41:42624279. MEDLINE
  • 48
    Fisher RI, Hubbard SM, De Vita VT, Berard CW, Wesley R, Cossman J, et al. Factors predicting long-term survival in diffuse mixed histiocytic or undifferentiated lymphoma. Blood 1981; 58:4551. MEDLINE
  • 49
    Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988; 318:733741. MEDLINE
  • 50
    Robertson L, Rice L, Riggs S, White M, Young J, Frazler O. Lymphomas after cardiac transplantation: Houston experience and successful therapy [abstr]. Blood 1990; 76:369A.
  • 51
    Manning KR, Powell BL, Peacock JE, Miller HS, Hackshaw BT. Effective combination chemotherapy for high-grade non-Hodgkin's lymphoma after cardiac transplant [abstr]. Blood 1991; 78:468A.
  • 52
    Blanche S, Le Deist F, Veber F, Lenoir G, Fischer AM, Brochier J, et al. Treatment of severe Epstein-Barr virus–induced polyclonal B-lymphocyte proliferation of anti–B-cell monoclonal antibodies. Ann Intern Med 1988; 108:199203. MEDLINE
  • 53
    Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier J, Niaudet P, et al. Anti–B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324:14511456. MEDLINE